Globus medical, inc. (GMED)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Cash flows from operating activities:
Net income

155,210

156,474

107,348

104,341

112,784

92,485

68,612

73,831

60,784

54,458

Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization

52,734

41,630

42,067

38,771

24,084

21,754

19,397

18,108

16,949

15,196

Amortization of premium (discount) on marketable securities

1,089

-1,677

-2,671

4,068

3,354

2,680

2,358

0

-

-

Write-down for excess and obsolete inventories

2,498

10,475

11,519

12,836

9,924

6,962

8,212

6,119

10,487

6,112

Stock-based compensation expense

26,085

21,899

14,686

11,382

9,639

7,111

5,177

4,635

3,286

4,025

Excess tax benefit related to nonqualified stock options

-

-

-

-

-

4,408

4,756

-

-

-

Allowance for doubtful accounts

3,026

957

1,718

685

1,465

318

693

363

105

397

Change in fair value of business acquisition liabilities

1,787

985

1,240

2,866

3,118

-1,131

-

-

-

0

Non-cash settlement of accrued expenses

-

-

-

4,632

8,405

0

-

-

-

-

Impairment of intangible assets

-

-

516

3,472

0

0

-

-

-

-

Change in fair value of interest rate swap

-

-

-

-

-

-

-

-

-

238

Change in deferred income taxes

4,302

971

8,292

-3,810

6,235

-4,379

-14,858

-6,079

2,057

1,999

(Gain)/loss on disposal of assets, net

-866

3,557

-

0

-

-

-

-

-

-

(Increase)/decrease in:
Restricted cash

-

-

-

-

2,749

23,370

0

0

-

-

Accounts receivable

18,306

21,789

24,955

4,668

4,193

12,667

9,612

6,886

4,672

6,560

Inventories

50,018

31,382

5,277

10,503

19,327

18,001

16,678

20,541

15,280

10,188

Prepaid expenses and other assets

12,263

7,496

4,774

-4,568

1,203

249

2,955

117

-460

-1,042

Increase/(decrease) in:
Accounts payable

773

-3,008

9,843

-23

-3,825

4,628

1,840

3,048

-1,355

1,295

Accounts payable to related party

-

-

-

-

-5,359

2,703

100

1,378

-696

1,425

Accrued expenses and other liabilities

7,043

14,728

-2,064

-18,164

-878

5,149

26,963

4,208

1,575

3,117

Income taxes payable/receivable

-673

-921

-3,772

6,634

-657

-413

8,978

-1,548

2,710

-792

Net cash provided by operating activities

171,975

181,643

159,058

147,823

124,007

79,172

93,471

76,519

76,410

71,288

Cash flows from investing activities:
Purchases of marketable securities

346,526

537,942

392,895

350,448

300,207

251,422

240,892

0

0

-

Maturities of marketable securities

247,008

278,049

240,353

281,885

188,702

184,567

40,560

0

0

-

Sales of marketable securities

53,786

106,388

122,512

52,802

57,728

27,737

13,637

0

0

-

Sales of short-term investments

-

-

-

-

-

-

-

-

-

300

Purchases of property and equipment

70,750

59,697

51,303

40,909

50,760

24,754

23,680

24,684

22,487

12,303

Collections/(issuance) of note receivable

-

30,000

-

30,000

0

0

-

-

-

-

Proceeds from sale of assets

-

5,000

-

0

-

-

-

-

-

-

Acquisition of businesses, net of cash acquired and purchases of intangible and other assets

23,799

14,825

29,944

76,068

48,513

36,128

16,775

6,031

7,500

0

Net cash used in investing activities

-140,281

-193,027

-111,277

-162,738

-153,050

-100,000

-227,150

-30,715

-29,987

-12,003

Cash flows from financing activities:
Repayments of long-term debt

-

-

-

-

-

-

-

-

5,253

340

Payment of business acquisition liabilities

6,597

6,739

10,109

5,404

1,200

1,200

1,300

1,100

400

0

Proceeds from exercise of stock options

31,036

39,309

11,735

5,874

5,477

9,738

7,555

1,504

886

1,321

Net proceeds from initial public offering

-

-

-

-

-

-

-

20,960

0

0

Payments for Repurchase of Common Stock

-

-

-

-

-

-

-

-

10,021

0

Excess tax benefit related to nonqualified stock options

-

-

-

-

-

4,408

4,756

2,661

54

787

Net cash provided by financing activities

24,439

32,570

1,626

470

4,277

12,946

11,011

24,025

-14,734

1,768

Effect of foreign exchange rate on cash

-156

-256

1,979

-1,894

153

185

230

-97

-722

-2

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect

55,977

20,930

51,386

-16,339

-24,613

-7,697

-122,438

69,732

30,967

61,051

Supplemental disclosures of cash flow information:
Interest paid

79

6

3

35

9

32

96

63

167

463

Income taxes paid

34,139

30,552

59,111

50,087

57,100

51,096

38,719

44,875

35,721

28,828